搜尋結果
Novo Nordisk raises outlook fuelled by obesity drug demand
Reuters· 4 小時前, opens new tab raised its 2024 outlook on Thursday and delivered better-than-expected ...
Ozempic Maker Novo Nordisk Beats Profit Forecasts Amid Weight Loss Drug Frenzy
Forbes· 5 小時前Danish pharma giant Novo Nordisk raised its 2024 outlook and beat profit expectations in its first-quarter earnings Thursday ...
Chicago-based Hyde Park Venture Partners closes $98M Fund IV with two investments made so far
TechCrunch· 23 小時前Midwest venture capital firms might always play catch-up to the coasts, but that’s not stopping ...